
E Trax 250mg/250mg Tablet
Marketer
Magbro Healthcare Pvt Ltd
Salt Composition
Tranexamic Acid (250mg) + Ethamsylate (250mg)
Overview E Trax 250mg/250mg Tablet
Tranexamic acid 250mg/250mg tablets are prescribed to manage excessive menstrual bleeding. This medication functions by inhibiting clot breakdown, thereby controlling heavy bleeding, and enhancing platelet aggregation for improved clot formation. Dosage timing is flexible—with or without food—but consistency is key; take it at the same time daily as directed by your physician. Continue treatment for the prescribed duration, even if symptoms improve. Missed doses should be taken immediately upon recall. Abrupt cessation requires prior medical consultation. Common adverse effects may include nausea, abdominal discomfort, headache, nasal stuffiness, sinusitis, skin rash, fatigue, and musculoskeletal pain. Diarrhea is also possible; increased fluid intake is recommended to mitigate dehydration. If no menstrual improvement is observed after three cycles, seek medical advice. Prior to initiating treatment, inform your doctor of any kidney issues, vaginal bleeding disorders, pregnancy, breastfeeding, or other concurrent medications. Regular eye examinations may be necessary during treatment.
Primary Ingredients of E Trax 250mg/250mg Tablet
The provided text is "undefined," which cannot be rephrased while maintaining meaning and intent. There is no text to rewrite.
Uses of E Trax 250mg/250mg Tablet
Profound menstrual blood loss
Major Benefits of E Trax 250mg/250mg Tablet:
Administer this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; do not crush, chew, or divide it. E Trax 250mg/250mg Tablets can be consumed with or without food, although consistent timing is recommended.
Common Side effects of E Trax 250mg/250mg Tablet:
- Nausea
- Stomach pain
- Diarrhea
- Headache
- Nasal congestion (stuffy nose)
- Sinus pain
- Sinus inflammation
- Rash
- Tiredness
- Musculoskeletal (bone, muscle or joint) pain
- Anemia (low number of red blood cells)
How to use E Trax 250mg/250mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the 250mg/250mg E Trax tablet whole; avoid chewing, crushing, or fracturing it. Consumption may coincide with meals or be taken independently, though consistent timing is recommended.
How E Trax 250mg/250mg Tablet works:
Each E Trax 250mg/250mg tablet unites Tranexamic Acid and Ethamsylate, two distinct medications. Tranexamic Acid, an antifibrinolytic agent, stabilizes blood clots, thereby reducing excessive blood loss. Ethamsylate, a hemostatic drug, enhances platelet aggregation and clot formation, simultaneously managing bleeding from minute capillaries.
SAFETY ADVICE
AlcoholUNSAFE
Concomitant use of E Trax 250mg/250mg tablets and alcohol may result in significant sedation.
PregnancyCONSULT YOUR DOCTOR
Data on the use of E Trax 250mg/250mg tablets in pregnancy is lacking. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of E Trax 250mg/250mg tablets with breastfeeding is lacking. Seek medical advice from your physician.
DrivingSAFE
Driving ability is typically unaffected by E Trax 250mg/250mg Tablets.
KidneyCAUTION
Patients with kidney impairment should use E Trax 250mg/250mg Tablets cautiously; dosage modification may be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of E Trax 250mg/250mg tablets in individuals with hepatic impairment is likely safe. Existing evidence indicates dose modification may be unnecessary; however, medical advice is recommended.
What if you forget to take E Trax 250mg/250mg Tablet :
Should you forget to take a E Trax 250mg/250mg Tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About E Trax 250mg/250mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | KINSHIP |
